(Q83802452)
Statements
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers (English)
S Rottey
B Sautois
J Kerger
L A D'Hondt
V Verschaeve
J-L Canon
C Dopchie
J M Vandenbulcke
N Whenham
J C Goeminne
M Clausse
D Verhoeven
P Glorieux
S Branders
P Dupont
J Schoonjans
O Feron